These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38062943)

  • 1. Respiratory syncytial virus infections - recent developments providing promising new tools for disease prevention.
    Broberg EK; Nohynek H
    Euro Surveill; 2023 Dec; 28(49):. PubMed ID: 38062943
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein.
    Beach SS; Hull MA; Ytreberg FM; Patel JS; Miura TA
    J Virol; 2022 Jul; 96(13):e0035322. PubMed ID: 35678603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients.
    Baier C; Huang J; Reumann K; Indenbirken D; Thol F; Koenecke C; Ebadi E; Heim A; Bange FC; Haid S; Pietschmann T; Fischer N
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):88. PubMed ID: 35729671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
    Mazur NI; Terstappen J; Baral R; Bardají A; Beutels P; Buchholz UJ; Cohen C; Crowe JE; Cutland CL; Eckert L; Feikin D; Fitzpatrick T; Fong Y; Graham BS; Heikkinen T; Higgins D; Hirve S; Klugman KP; Kragten-Tabatabaie L; Lemey P; Libster R; Löwensteyn Y; Mejias A; Munoz FM; Munywoki PK; Mwananyanda L; Nair H; Nunes MC; Ramilo O; Richmond P; Ruckwardt TJ; Sande C; Srikantiah P; Thacker N; Waldstein KA; Weinberger D; Wildenbeest J; Wiseman D; Zar HJ; Zambon M; Bont L
    Lancet Infect Dis; 2023 Jan; 23(1):e2-e21. PubMed ID: 35952703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection.
    Welliver RC
    Semin Perinatol; 1998 Feb; 22(1):87-95. PubMed ID: 9523402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palivizumab in the prophylaxis of respiratory syncytial virus infection.
    Cardenas S; Auais A; Piedimonte G
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):719-26. PubMed ID: 16207163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic characterisation of respiratory syncytial virus: a novel system for whole genome sequencing and full-length G and F gene sequences.
    Iglesias-Caballero M; Camarero-Serrano S; Varona S; Mas V; Calvo C; García ML; García-Costa J; Vázquez-Morón S; Monzón S; Campoy A; Cuesta I; Pozo F; Casas I
    Euro Surveill; 2023 Dec; 28(49):. PubMed ID: 38062945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus infection in the modern era.
    Ludlow M
    Curr Opin Infect Dis; 2023 Jun; 36(3):155-163. PubMed ID: 36939556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis.
    Sun M; Lai H; Na F; Li S; Qiu X; Tian J; Zhang Z; Ge L
    JAMA Netw Open; 2023 Feb; 6(2):e230023. PubMed ID: 36800182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood.
    Scotta MC; Stein RT
    J Pediatr (Rio J); 2023; 99 Suppl 1(Suppl 1):S4-S11. PubMed ID: 36402228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.
    Meissner HC; Welliver RC; Chartrand SA; Law BJ; Weisman LE; Dorkin HL; Rodriguez WJ
    Pediatr Infect Dis J; 1999 Mar; 18(3):223-31. PubMed ID: 10093942
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing Pediatric Respiratory Syncytial Virus Infection.
    Domachowske J; Halczyn J; Bonville CA
    Pediatr Ann; 2018 Sep; 47(9):e371-e376. PubMed ID: 30208197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection.
    Rodriguez-Fernandez R; Mejias A; Ramilo O
    Pediatr Infect Dis J; 2021 May; 40(5S):S35-S39. PubMed ID: 34042909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of respiratory syncytial virus infections.
    Bricks LF
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(3):79-90. PubMed ID: 11514908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP).
    Francisco L; Cruz-Cañete M; Pérez C; Couceiro JA; Otheo E; Launes C; Rodrigo C; Jiménez AB; Llorente M; Montesdeoca A; Rumbao J; Calvo C; Frago S; Tagarro A
    An Pediatr (Engl Ed); 2023 Oct; 99(4):257-263. PubMed ID: 37743207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Respiratory Syncytial Virus Infection: From Vaccine to Antibody.
    Huang K; Wu H
    Microbiol Spectr; 2014 Aug; 2(4):AID-0014-2014. PubMed ID: 26104207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expert recommendations for the prevention and control of pediatric respiratory syncytial virus infections in China (2023 edition)].
    ; ;
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3155-3159. PubMed ID: 37879868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.
    Empey KM; Peebles RS; Kolls JK
    Clin Infect Dis; 2010 May; 50(9):1258-67. PubMed ID: 20235830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody and Local Cytokine Response to Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults.
    Yu X; Lakerveld AJ; Imholz S; Hendriks M; Ten Brink SCA; Mulder HL; de Haan K; Schepp RM; Luytjes W; de Jong MD; van Beek J; van Kasteren PB
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies.
    Shang Z; Tan S; Ma D
    Int J Biol Sci; 2021; 17(14):4073-4091. PubMed ID: 34671221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.